Sign in

CIK 0001088856

  • Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770487658
Phone
+1 650-688-8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
  1. 4/A Open-market sale Chief Development Officer sold 4,500 shares at $80.90 ($364,070)
  2. 4 Open-market sale Chief Development Officer sold 4,500 shares at $80.90 ($364,070)
  3. 4 Planned sale Chief Development Officer sold 20,000 shares at an average $75.36 ($1,507,122)
  4. 4 Planned sale See Remarks sold 5,000 shares at $73.65 ($368,245)
  5. 4 Planned sale Chief Executive Officer sold 40,000 shares at an average $74.58 ($2,983,119)
  6. 4 Planned sale See Remarks sold 20,000 shares at $73.99 ($1,479,816)
  7. 4 Planned sale Director sold 2,200 shares at $87.54 ($192,588)
  8. 4 Planned sale Chief Development Officer sold 20,000 shares at $89.94 ($1,798,782)
  9. 4 Planned sale Chief Executive Officer sold 40,000 shares at an average $85.08 ($3,403,253)
  10. 4 Planned sale See Remarks sold 5,000 shares at an average $84.75 ($423,766)
  11. 4 Planned sale See Remarks sold 20,000 shares at an average $85.06 ($1,701,232)
  12. 4 Gift Chief Development Officer gave 200 shares (gift)
  13. 4 Gift Director gave 7,393 shares (gift)
  14. 4 Planned sale Director sold 2,200 shares at $72.45 ($159,390)
  15. 4 Shares withheld for taxes Director gave up 3,607 shares (to pay taxes)
  16. 4 Planned sale Chief Development Officer sold 20,000 shares at an average $70.49 ($1,409,848)
  17. 4 Planned sale See Remarks sold 5,000 shares at an average $70.25 ($351,247)
  18. 4 Planned sale See Remarks sold 20,000 shares at an average $70.49 ($1,409,828)
  19. 4 Planned sale Chief Executive Officer sold 40,000 shares at an average $70.53 ($2,821,033)
  20. 4 Grant or award Chief Financial Officer acquired 400 shares (grant or award)

Page 6 of 60 · 1,196 filings